title: European Society of Hypertension Working Group on Obesity: obesity drugs and cardiovascular outcomes.
authors.forename: Jens
authors.initials: J
authors.lastname: Jordan
authors.forename: Markus
authors.initials: M
authors.lastname: Schlaich
authors.forename: Josep
authors.initials: J
authors.lastname: Redon
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Narkiewicz
authors.forename: Friedrich C
authors.initials: FC
authors.lastname: Luft
authors.forename: Guido
authors.initials: G
authors.lastname: Grassi
authors.forename: John
authors.initials: J
authors.lastname: Dixon
authors.forename: Gavin
authors.initials: G
authors.lastname: Lambert
authors.forename: Stefan
authors.initials: S
authors.lastname: Engeli
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects / Q000627:therapeutic use*; D050110:Bariatric Surgery; D002318:Cardiovascular Diseases / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D005060:Europe; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D009765:Obesity / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D012955:Societies, Medical; D016896:Treatment Outcome
chemical_list: D019440:Anti-Obesity Agents